Details for New Drug Application (NDA): 083149
The generic ingredient in PBZ is tripelennamine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the tripelennamine hydrochloride profile page.
Summary for 083149
| Tradename: | PBZ |
| Applicant: | Novartis |
| Ingredient: | tripelennamine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
